Varda Rotter
- Oncology top 0.05%
- Cancer-related Molecular Pathways 163
- Cancer Cells and Metastasis 16
- Biotechnology top 0.05%
- Cancer Research and Treatments 61
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 21
- Molecular Biology top 0.2%
- Epigenetics and DNA Methylation 42
- RNA modifications and cancer 31
- Cell death mechanisms and regulation 19
- Hematology top 1%
-
- Virus-based gene therapy research 26
- Co-authors
- Moshe OrenNaomi GoldfingerRan BroshD. WolfMiron ProkocimerNoa RivlinAlex SigalIdo Goldstein
- Cited by
- OncologyBiotechnologyCancer Research
- Journals
- Molecular and Cellular Biology (26 papers)Oncogene (20 papers)Cell Death and Differentiation (13 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Varda Rotter
270 papers receiving 17.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 10.2k
- Biotechnology 2.5k
- Cancer Research 4.1k
- Molecular Biology 11.9k
- Hematology 775
Countries citing papers authored by Varda Rotter
This map shows the geographic impact of Varda Rotter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varda Rotter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varda Rotter more than expected).
Fields of papers citing papers by Varda Rotter
This network shows the impact of papers produced by Varda Rotter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varda Rotter. The network helps show where Varda Rotter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Varda Rotter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2018 | 17 | |
| 3 | 2018 | 9 | |
| 4 | 2018 | 29 | |
| 5 | 2010 | 64 | |
| 6 | 2009 | 56 | |
| 7 | 2009 | 23 | |
| 8 | 2007 | 170 | |
| 9 | 2007 | 19 | |
| 10 | 2006 | 31 | |
| 11 | 2006 | 86 | |
| 12 | 2005 | 51 | |
| 13 | 2004 | 29 | |
| 14 | 2003 | 18 | |
| 15 | 2003 | 170 | |
| 16 | 2001 | 60 | |
| 17 | 1997 | 24 | |
| 18 | Nuclear localization is essential for the activity of p53 protein. | 1991 | 166 |
| 19 | 1986 | 51 | |
| 20 | 1984 | 15 |
About Varda Rotter
Varda Rotter is a scholar working on Biotechnology, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 270 papers that have together received 18.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (163 papers), Cancer Research and Treatments (61 papers), Epigenetics and DNA Methylation (42 papers), RNA modifications and cancer (31 papers), Virus-based gene therapy research (26 papers), Cancer, Hypoxia, and Metabolism (21 papers), Cell death mechanisms and regulation (19 papers) and Cancer Cells and Metastasis (16 papers). The work is most often cited by research in Oncology (10.2k citations), Biotechnology (2.5k citations), Cancer Research (4.1k citations), Molecular Biology (11.9k citations) and Hematology (775 citations). Varda Rotter has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Moshe Oren, Naomi Goldfinger, Ran Brosh, D. Wolf, Miron Prokocimer, Noa Rivlin, Alex Sigal, Ido Goldstein, Alina Molchadsky and Gad Shaulsky. Their work appears in journals such as Molecular and Cellular Biology, Oncogene, Cell Death and Differentiation, Proceedings of the National Academy of Sciences and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.